Keyword: Longitude Capital
With each device and the data it generates adding to the workload of cardiac clinics, the startup sees the burden on clinics becoming too much.
The financing sets Rapid Micro up to support the growth of technology that automates the detection of microbes at drug production plants.
The financing comes as Axonics closes in on the end of a clinical trial that will set it up to market the device in the U.S.
The series B round equips Amphora to take its minimally invasive, cystoscopic device into the last step of clinical development next year.
Longitude Venture Partners III has set its sights on a $525 million raise, according to an SEC filing.